自从1959年瑞典的Elmoqwist及Senning埋植了世界上第1个心脏起搏器治疗完全性房室传导阻滞以来,起搏器的发展已近30年。30年来,特别是最近10年,心脏起搏技术获得了飞速的发展,应用指征大为扩展。由于起搏器的应用使全世界数百万患症候性心动过缓的病人的生命得以挽救,因此心脏起搏器已成为生物医学工程中最有代表性的成就和心血管疾病治疗的重要方法。目前的心脏起搏器已不是一个简单的电刺激器,而是具有感知体内生理信息、根据代 Pacemakers have been developing for almost 30 years since 1959 when Elmoqwist and Senning of Sweden have implanted the world’s first pacemaker to treat complete atrioventricular block. 30 years, especially in the last 10 years, rapid development of pacing technology has been achieved, the application of indications greatly expanded. Because pacemakers have saved the lives of millions of patients with symptomatic bradycardia around the world, pacemakers have become the most representative achievement in biomedical engineering and an important method of treatment for cardiovascular disease . Current pacemakers are no longer a simple electrical stimulator, but rather have a perception of in vivo physiological information, according to the generation